ChromaDex

-$0.07 (-1.13%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ChromaDex and other ETFs, options, and stocks.

About CDXC

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+).

CEO

Robert N. Fried

Employees

110

Headquarters

Los Angeles, California

Founded

1999

CDXC Key Statistics

Market Cap

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

381.14K

High Today

$6.31

Low Today

$6.04

Open Price

$6.15

Volume

285.87K

52 Week High

$23.66

52 Week Low

$4.36

CDXC News

Simply Wall StOct 24

ChromaDex Corporation's Profit Outlook

We feel now is a pretty good time to analyse ChromaDex Corporation's (NASDAQ:CDXC) business as it appears the company may be on the cusp of a considerable accom

CDXC Earnings

-$0.12

-$0.08

-$0.04

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Nov 3, After Hours

Why Robinhood?

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). View more

ChromaDex Corporation's Profit Outlook

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+).